The present disclosure relates generally to orthopedics and spinal surgery. More specifically, the present disclosure relates to intervertebral prosthetic discs.
In human anatomy, the spine is a generally flexible column that can take tensile and compressive loads. The spine also allows bending motion and provides a place of attachment for ribs, muscles and ligaments. Generally, the spine is divided into three sections: the cervical spine, the thoracic spine and the lumbar spine. The sections of the spine are made up of individual bones called vertebrae. Also, the vertebrae are separated by intervertebral discs, which are situated between adjacent vertebrae.
The intervertebral discs function as shock absorbers and as joints. Further, the intervertebral discs can absorb the compressive and tensile loads to which the spinal column may be subjected. At the same time, the intervertebral discs can allow adjacent vertebral bodies to move relative to each other a limited amount, particularly during bending, or flexure, of the spine. Thus, the intervertebral discs are under constant muscular and/or gravitational pressure and generally, the intervertebral discs are the first parts of the lumbar spine to show signs of deterioration.
Facet joint degeneration is also common because the facet joints are in almost constant motion with the spine. In fact, facet joint degeneration and disc degeneration frequently occur together. Generally, although one may be the primary problem while the other is a secondary problem resulting from the altered mechanics of the spine, by the time surgical options are considered, both facet joint degeneration and disc degeneration typically have occurred. For example, the altered mechanics of the facet joints and/or intervertebral disc may cause spinal stenosis, degenerative spondylolisthesis, and degenerative scoliosis.
One surgical procedure for treating these conditions is spinal arthrodesis, i.e., spine fusion, which can be performed anteriorally, posteriorally, and/or laterally. The posterior procedures include in-situ fusion, posterior lateral instrumented fusion, transforaminal lumbar interbody fusion (“TLIF”) and posterior lumbar interbody fusion (“PLIF”). Solidly fusing a spinal segment to eliminate any motion at that level may alleviate the immediate symptoms, but for some patients maintaining motion may be beneficial. It is also known to surgically replace a degenerative disc or facet joint with an artificial disc or an artificial facet joint, respectively.
An intervertebral prosthetic disc is disclosed. The intervertebral prosthetic disc can be installed within an intervertebral space between adjacent first and second vertebrae. The intervertebral prosthetic disc can include a first component that is configured to engage the first vertebra, a second component that is configured to engage the second vertebra, and at least one expandable motion limiter. Further, the expandable motion limiter can be configured to move from a deflated position to at least one inflated position.
In another embodiment, an intervertebral prosthetic disc is disclosed and can be installed within an intervertebral space between an inferior vertebra and a superior vertebra. In this embodiment, the intervertebral prosthetic disc can include an inferior component that is configured to engage the inferior vertebra and a superior component that is configured to engage the superior vertebra. The superior component can include a superior support plate and at least one expandable motion limiter that can be attached to the superior support plate. The expandable motion limiter can be configured to move from a deflated position to one of a plurality of inflated positions.
In yet another embodiment an intervertebral prosthetic disc is disclosed and can be installed within an intervertebral space between an inferior vertebra and a superior vertebra. In this embodiment, the intervertebral prosthetic disc can include a superior component configured to engage the inferior vertebra and an inferior component configured to engage the inferior vertebra. Also, the inferior component can include an inferior support plate and at least one expandable motion limiter that can be attached to the inferior support plate. The expandable motion limiter can be configured to move from a deflated position to one of a plurality of inflated positions.
In yet another embodiment an intervertebral prosthetic disc is disclosed and can be installed within an intervertebral space between an inferior vertebra and a superior vertebra. In this embodiment, the intervertebral prosthetic disc can include a superior component configured to engage the superior vertebra and an inferior component configured to engage the inferior vertebra. Also, the superior component can include a superior support plate and at least one expandable motion limiter that can be attached to the superior support plate. The inferior component can include an inferior support plate and at least one expandable motion limiter that can be attached to the inferior support plate in a position(s) which would not contact or otherwise interfere with the motion limiter(s) of the superior plate through its/their full range of motion. The expandable motion limiter can be configured to move from a deflated position to one of a plurality of inflated positions.
In still another embodiment, a method of installing an intervertebral prosthetic disc within an intervertebral space between an inferior vertebra and a superior vertebra of a patient is disclosed. The method can include implanting the intervertebral prosthetic disc within the intervertebral space and inflating at least one expandable motion limiter within the intervertebral prosthetic disc.
Description of Relevant Anatomy
Referring initially to
As shown in
As depicted in
In a particular embodiment, if one of the intervertebral lumbar discs 122, 124, 126, 128, 130 is diseased, degenerated, damaged, or otherwise in need of replacement, that intervertebral lumbar disc 122, 124, 126, 128, 130 can be at least partially removed and replaced with an intervertebral prosthetic disc according to one or more of the embodiments described herein. In a particular embodiment, a portion of the intervertebral lumbar disc 122, 124, 126, 128, 130 can be removed via a discectomy, or a similar surgical procedure, well known in the art. Further, removal of intervertebral lumbar disc material can result in the formation of an intervertebral space (not shown) between two adjacent lumbar vertebrae.
Referring to
As illustrated in
It is well known in the art that the vertebrae that make up the vertebral column have slightly different appearances as they range from the cervical region to the lumbar region of the vertebral column. However, all of the vertebrae, except the first and second cervical vertebrae, have the same basic structures, e.g., those structures described above in conjunction with
Referring to
In a particular embodiment, the metal containing materials can be metals. Further, the metal containing materials can be ceramics. Also, the metals can be pure metals or metal alloys. The pure metals can include titanium. Moreover, the metal alloys can include stainless steel, a cobalt-chrome-molybdenum alloy, e.g., ASTM F-999 or ASTM F-75, a titanium alloy, or a combination thereof.
The polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Alternatively, the components 500, 600 can be made from any other substantially rigid biocompatible materials.
In a particular embodiment, the superior component 500 includes a superior support plate 502 that has a superior articular surface 504 and a superior bearing surface 506. In a particular embodiment, the superior articular surface 504 can be generally curved and the superior bearing surface 506 can be substantially flat. In an alternative embodiment, the superior articular surface 504 can be substantially flat and at least a portion of the superior bearing surface 506 can be generally curved.
In a particular embodiment, after installation, the superior bearing surface 506 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the superior bearing surface 506 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the superior bearing surface 506 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
As further illustrated in
For example, the polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials; or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Also, the silicone materials can include a silicone hydrogel.
In an alternative embodiment, the injectable extended use approved medical materials can include one or more fluids such as sterile water, saline, sterile air, or a combination thereof. In alternative embodiments, the expandable motion limiters can be inflated with one or more of the following: fibroblasts, lipoblasts, chondroblasts, differentiated stem cells, a combination thereof, or another biologic factor which would create a motion limiting tissue when injected into a bioresorbable motion limiting scaffold.
As shown in
As shown, the superior support plate 502 can also include a second port 536 that is in fluid communication with a second fluid channel 536 that provides fluid communication to the second expandable motion limiter 522. The second expandable motion limiter 522 can be inflated with an injectable extended use approved medical material that is delivered to the second expandable motion limiter 522 via the second port 536 and the second fluid channel 536.
The superior support plate 502 can also include a fourth port 544 that is in fluid communication with a fourth fluid channel 546 that provides fluid communication to the fourth expandable motion limiter 526. The fourth expandable motion limiter 526 can be inflated with an injectable extended use approved medical material that is delivered to the fourth expandable motion limiter 526 via the fourth port 544 and the fourth fluid channel 546.
As illustrated in
In a particular embodiment, the inferior component 600 includes an inferior support plate 602 that has an inferior articular surface 604 and an inferior bearing surface 606. In a particular embodiment, the inferior articular surface 604 can be generally curved and the inferior bearing surface 606 can be substantially flat. In an alternative embodiment, the inferior articular surface 604 can be substantially flat and at least a portion of the inferior bearing surface 606 can be generally curved.
In a particular embodiment, after installation, the inferior bearing surface 606 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the inferior bearing surface 606 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the inferior bearing surface 606 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
The inferior support plate 602 can also include a first motion limiter engagement recess 622, a second motion limiter engagement recess 624, a third motion limiter engagement recess 626, and a fourth motion limiter engagement recess 628. In a particular embodiment, the motion limiter engagement recesses 620, 622, 624, 626 are arranged radially around the depression 608, e.g., in a pattern that mirrors the pattern of the expandable motion limiters 520, 522, 524, 526. Further, each motion limiter engagement recess 620, 622, 624, 626 is sized and shaped to at least partially receive a corresponding expandable motion limiter 520, 522, 524, 526.
In a particular embodiment, each expandable motion limiter 520, 522, 524, 526 cooperates with a respective motion limiter engagement recess 620, 622, 624, 626 in order to limit the motion of the superior component 500 with respect to the inferior component 600. For example, by inflating two expandable motion limiters on one side of the projection 508, a surgeon is able to limit flexion on that side of the projection 508 and as such, limit the relative motion of the superior component 500 with respect to the inferior component 600. Further, this allows the surgeon to limit the motion of a superior vertebra with respect to an inferior vertebra.
The flexibility to alter the range of motion of the intervertebral prosthetic device 400 provided by the expandable motion limiters 520, 522, 524, 526 can allow a surgeon to compensate for a deformity in the segment of the spinal column that includes, or is adjacent to, the superior vertebra and inferior vertebra in question. For example, if a patient's spine is curved in a particular direction, one or more motion limiters 520, 522, 524, 526 opposite the curvature can be inflated to compensate for the curvature. Before or during the surgery, the surgeon can determine any spinal deformity using an X-Ray device, a fluoroscopy device, a computed tomography (CT) device, or any other similar device well known in the art.
In a particular embodiment, as shown in
In a particular embodiment, the overall height of the intervertebral prosthetic device 400 can be in a range from fourteen millimeters to forty-six millimeters (14-46 mm). Further, the installed height of the intervertebral prosthetic device 400 can be in a range from eight millimeters to sixteen millimeters (8-16 mm). In a particular embodiment, the installed height can be substantially equivalent to the distance between an inferior vertebra and a superior vertebra when the intervertebral prosthetic device 400 is installed there between.
In a particular embodiment, the length of the intervertebral prosthetic device 400, e.g., along a longitudinal axis, can be in a range from thirty millimeters to forty millimeters (30-40 mm). Additionally, the width of the intervertebral prosthetic device 400, e.g., along a lateral axis, can be in a range from twenty-five millimeters to forty millimeters (25-40 mm). Moreover, in a particular embodiment, each keel 548, 648 can have a height in a range from three millimeters to fifteen millimeters (3-15 mm).
Although depicted in the Figures as a two piece-design, in alternative embodiments, multiple-piece designs can be employed. For example, in an alternative embodiment, the projection 508 is not fixed or unitary with either of the support plates 502, 602 and, instead, is configured as a substantially rigid spherical member (not shown) that can independently articulate with each support plate 502, 602. Additionally or alternatively, each component can comprise multiple components (not shown). These components can articulate with or be fixed to the support plates 502, 602. Furthermore, expandable motion limiters can be configured to limit relative motion between any of the components described above or among multiple components.
Installation of the First Embodiment within an Intervertebral Space
Referring to
As shown in
Also, as shown in
As illustrated in
In a particular embodiment, the intervertebral prosthetic disc 400 can allow angular movement in any radial direction relative to the intervertebral prosthetic disc 400. For example,
Further, as depicted in
In a particular embodiment, each expandable motion limiter 520, 522, 524, 526 can cooperate with a respective motion limiter engagement recess 620, 622, 624, 626 in order to limit the motion of the superior component 500 with respect to the inferior component 600. However, each expandable motion limiter 520, 522, 524, 526 can be inflated to further limit the relative motion between the superior component 500 and the inferior component 600.
In one or more alternative embodiments, a surgeon can use a posterior approach or a lateral approach to implant an intervertebral prosthetic device. As such, the patient may be secured in a different position, e.g., in a prone position for a posterior approach or in a lateral decubitus position for a lateral approach.
Moving to block 1304, the location of the affected disc is marked on patient's abdomen, e.g., with the aid of fluoroscopy. At block 1306, the patient's anterior lumbar spine is exposed. The anterior lumbar spine can be approached through a transperitoneal or a retroperitoneal exposure using the appropriate instruments and retractors. For example, an anterior approach can be facilitated with the aid of a surgical retractor system, e.g., the Medtronic Sofamor Danek Endoring™ Surgical Retractor System. At block 1308, a surgical retractor system can be installed to keep the surgical field open during the surgery.
Proceeding to block 1310, the midline of the spine at the operative level is located. For example, the midline of the spine can be located using an intra-operative anterior-posterior (A-P) image. At block 1312, once the midline is located, a center marking pin can be installed. Moving to block 1314, a discectomy of the affected disc can be performed. At block 1316, the superior vertebra and inferior vertebra can be mobilized and distracted. Further, at block 1318, all posterior osteophytes can be removed.
Moving to block 1320, the adhesion of the posterior ligament can be released from the superior vertebra and inferior vertebra. At block 1322, the angle of the intervertebral disc space is measured. Moreover, at block 1324, the intervertebral space is measured to determine a height of an intervertebral prosthetic disc to be implanted into the patient, e.g., into the intervertebral space between the superior vertebra and the inferior vertebra. At block 1326, the superior and inferior vertebrae are prepared to receive a prosthetic disc, e.g., an intervertebral prosthetic disc according to one or more of the embodiments described herein. In a particular embodiment, the preparation of the superior and inferior vertebrae may include removing portions of the cortical rim of each vertebra. Further, the preparation may include cutting one or more keel grooves in the cortical rim of each vertebra.
Proceeding to block 1328, the prosthetic disc can be placed within a loading block. At block 1330, the prosthetic disc can be retrieved from the loading block using an implant inserter that is designed to engage a prosthetic disc, e.g., an intervertebral prosthetic disc according to one or more of the embodiments described herein. Moving to block 1332, a prosthetic disc can be implanted.
At decision step 1334, it can be determined whether to inflate one or more of the expandable motion limiters that are incorporated into the design of the intervertebral prosthetic disc. In a particular embodiment, that determination can be at least partially based on one or more X-rays taken prior to the surgery or during the surgery. Additionally, that determination can be at least partially based on an inspection of the patient's spine during the surgery. Further, that determination can be at least partially based on one or more measurements taken during the surgery.
If it is determined to inflate one or more of the expandable motion limiters, the method proceeds to block 1336 and an injectable extended use approved medical material can be injected into one or more of the expandable motion limiters. Accordingly, the one or more expandable motion limiters can be inflated from a deflated position to one of a plurality of inflated positions—up to a maximum inflated position. In a particular embodiment, the volume of material that is injected into the one or more expandable motion limiters can be used to determine the inflated position of the one or more expandable motion limiters. Alternatively, the pressure of the material that is injected into the one or more expandable motion limiters can be used to determine the inflated position of the one or more expandable motion limiters.
At block 1338, the movement of the patient's spine is checked. For example, the adjustable surgical table can be moved in order to slightly flex the patient's spine. Moving to decision step 1340, it can be determined whether the movement is proper, i.e., whether the expandable motion limiters are properly limiting the motion of the patient's spine. Further, it can be determined whether the expandable motion limiters are properly limiting the motion of the superior vertebra with respect to the inferior vertebra.
At decision step 1340, if the one or more expandable motion limiters are not properly limiting the motion of the patient's spine, the method can return to block 1336 and more injectable extended use approved medical material can be injected into the one or more expandable motion limiters. As such, each of the one or more expandable motion limiters can be inflated from a first inflated position to a second inflated position. From block 1336, the method can continue as described herein. On the other hand, at decision step 1340, if the one or more expandable motion limiters are properly limiting the motion of the patient's spine, the method continues to block 1342 and the implant inserter can be removed from the intervertebral prosthetic disc and the surgical field.
Moving to block 1344, the one or more expandable motion limiters can be sealed. In one embodiment, a screw can be inserted into each port associated with each expandable motion limiter. In another embodiment, the polymer may be self-sealing, i.e., a polymer may be used that can cure under the ambient conditions of the surgery. In such an embodiment, the polymer can cure within each fluid channel through which the polymer can be injected and block the fluid channel. In yet another embodiment, a one-way valve can be installed within each fluid channel of the intervertebral prosthetic disc adjacent to, or downstream from, each port. As such, each one-way valve can allow polymer to be injected into the intervertebral prosthetic disc and prevent the polymer from be extruded from the intervertebral prosthetic disc.
Continuing to block 1346, the intervertebral space can be irrigated. Further, at block 1348, the retractor system can be removed. At block 1350, a retroperitoneal drainage can be inserted into the wound. Additionally, at block 1352, the wound can be closed. Moving to block 1354, postoperative care can be initiated. The method ends at step 1556.
Returning to decision step 1334, when it is determined not to inflate one or more of the expandable motion limiters, the method proceeds to block 1358 and the implant inserter is removed. The method can move to block 1346 and continue as described herein.
Referring to
In a particular embodiment, the metal containing materials can be metals. Further, the metal containing materials can be ceramics. Also, the metals can be pure metals or metal alloys. The pure metals can include titanium. Moreover, the metal alloys can include stainless steel, a cobalt-chrome-molybdenum alloy, e.g., ASTM F-999 or ASTM F-75, a titanium alloy, or a combination thereof.
The polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Alternatively, the components 1500, 1600 can be made from any other substantially rigid biocompatible materials.
In a particular embodiment, the superior component 1500 includes a superior support plate 1502 that has a superior articular surface 1504 and a superior bearing surface 1506. In a particular embodiment, the superior articular surface 1504 can be generally curved and the superior bearing surface 1506 can be substantially flat. In an alternative embodiment, the superior articular surface 1504 can be substantially flat and at least a portion of the superior bearing surface 1506 can be generally curved.
In a particular embodiment, after installation, the superior bearing surface 1506 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the superior bearing surface 1506 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the superior bearing surface 1506 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
As further illustrated in
For example, the polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Also, the silicone materials can include a silicone hydrogel.
In an alternative embodiment, the injectable extended use approved medical materials can include one or more fluids such as sterile water, saline, sterile air, or a combination thereof. In further alternative embodiments, the expandable motion limiters can be inflated with one or more of the following: fibroblasts, lipoblasts, chondroblasts, differentiated stem cells, a combination thereof, or another biologic factor which would create a motion limiting tissue when injected into a bioresorbable motion limiting scaffold.
As shown in
As shown, the superior support plate 1502 can also include a second port 1536 that is in fluid communication with a second fluid channel 1536 that provides fluid communication to the second expandable motion limiter 1522. The second expandable motion limiter 1522 can be inflated with an injectable extended use approved medical material that is delivered to the second expandable motion limiter 1522 via the second port 1536 and the second fluid channel 1536.
The superior support plate 1502 can also include a fourth port 1544 that is in fluid communication with a fourth fluid channel 1546 that provides fluid communication to the fourth expandable motion limiter 1526. The fourth expandable motion limiter 1526 can be inflated with an injectable extended use approved medical material that is delivered to the fourth expandable motion limiter 1526 via the fourth port 1544 and the fourth fluid channel 1546.
As illustrated in
As depicted in
In a particular embodiment, after installation, the inferior bearing surface 1606 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the inferior bearing surface 1606 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the inferior bearing surface 1606 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
The inferior support plate 1602 can also include a first motion limiter engagement recess 1622, a second motion limiter engagement recess 1624, a third motion limiter engagement recess 1626, and a fourth motion limiter engagement recess 1628. In a particular embodiment, the motion limiter engagement recesses 1620, 1622, 1624, 1626 are arranged radially around the depression 1608, e.g., in a pattern that mirrors the pattern of the expandable motion limiters 1520, 1522, 1524, 1526. Further, each motion limiter engagement recess 1620, 1622, 1624, 1626 is sized and shaped to at least partially receive a corresponding expandable motion limiter 1520, 1522, 1524, 1526.
In a particular embodiment, each expandable motion limiter 1520, 1522, 1524, 1526 cooperates with a respective motion limiter engagement recess 1620, 1622, 1624, 1626 in order to limit the motion of the superior component 1500 with respect to the inferior component 1600. For example, by inflating two expandable motion limiters on one side of the projection 1508, a surgeon is able to limit flexion on that side of the projection 1508 and as such, limit the relative motion of the superior component 1500 with respect to the inferior component 1600. Further, this allows the surgeon to limit the motion of a superior vertebra with respect to an inferior vertebra.
The flexibility to alter the range of motion of the intervertebral prosthetic device 1400 provided by the expandable motion limiters 1520, 1522, 1524, 1526 can allow a surgeon to compensate for a deformity in the segment of the spinal column that includes, or is adjacent to, the superior vertebra and inferior vertebra in question. For example, if a patient's spine is curved in a particular direction, one or more motion limiters 1520, 1522, 1524, 1526 opposite the curvature can be inflated to compensate for the curvature. Before or during the surgery, the surgeon can determine any spinal deformity using an X-Ray device, a fluoroscopy device, a computed tomography (CT) device, or any other similar device well known in the art.
In a particular embodiment, as shown in
In a particular embodiment, the overall height of the intervertebral prosthetic device 1400 can be in a range from fourteen millimeters to forty-six millimeters (14-46 mm). Further, the installed height of the intervertebral prosthetic device 1400 can be in a range from eight millimeters to sixteen millimeters (8-16 mm). In a particular embodiment, the installed height can be substantially equivalent to the distance between an inferior vertebra and a superior vertebra when the intervertebral prosthetic device 1400 is installed there between.
In a particular embodiment, the length of the intervertebral prosthetic device 1400, e.g., along a longitudinal axis, can be in a range from thirty millimeters to forty millimeters (30-40 mm). Additionally, the width of the intervertebral prosthetic device 400, e.g., along a lateral axis, can be in a range from twenty-five millimeters to forty millimeters (25-40 mm). Moreover, in a particular embodiment, each keel 1548, 1648 can have a height in a range from three millimeters to fifteen millimeters (3-15 mm).
Although depicted in the Figures as a two piece-design, in alternative embodiments, multiple-piece designs can be employed. For example, in an alternative embodiment, the projection 1508 is not fixed or unitary with either of the support plates 1502, 1602 and, instead, is configured as a substantially rigid spherical member (not shown) that can independently articulate with each support plate 1502, 1602. Additionally or alternatively, each component can comprise multiple components (not shown). These components can articulate with or be fixed to the support plates 1502, 1602. Furthermore, expandable motion limiters can be configured to limit relative motion between any of the components described above or among multiple components.
Referring to
In a particular embodiment, the metal containing materials can be metals. Further, the metal containing materials can be ceramics. Also, the metals can be pure metals or metal alloys. The pure metals can include titanium. Moreover, the metal alloys can include stainless steel, a cobalt-chrome-molybdenum alloy, e.g., ASTM F-999 or ASTM F-75, a titanium alloy, or a combination thereof.
The polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Alternatively, the components 2100, 2200 can be made from any other substantially rigid biocompatible materials.
In a particular embodiment, the inferior component 2100 includes an inferior support plate 2102 that has an inferior articular surface 2104 and an inferior bearing surface 2106. In a particular embodiment, the inferior articular surface 2104 can be generally curved and the inferior bearing surface 2106 can be substantially flat. In an alternative embodiment, the inferior articular surface 2104 can be substantially flat and at least a portion of the inferior bearing surface 2106 can be generally curved.
In a particular embodiment, after installation, the inferior bearing surface 2106 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the inferior bearing surface 2106 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the inferior bearing surface 2106 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
As further illustrated in
For example, the polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Also, the silicone materials can include a silicone hydrogel.
In an alternative embodiment, the injectable extended use approved medical materials can include one or more fluids such as sterile water, saline, sterile air, or a combination thereof. In alternative embodiments, the expandable motion limiters can be inflated with one or more of the following: fibroblasts, lipoblasts, chondroblasts, differentiated stem cells, a combination thereof, or another biologic factor which would create a motion limiting tissue when injected into a bioresorbable motion limiting scaffold.
As shown in
As shown, the inferior support plate 2102 can also include a second port 2136 that is in fluid communication with a second fluid channel 2136 that provides fluid communication to the second expandable motion limiter 2122. The second expandable motion limiter 2122 can be inflated with an injectable extended use approved medical material that is delivered to the second expandable motion limiter 2122 via the second port 2136 and the second fluid channel 2136.
The inferior support plate 2102 can also include a fourth port 2144 that is in fluid communication with a fourth fluid channel 2146 that provides fluid communication to the fourth expandable motion limiter 2126. The fourth expandable motion limiter 2126 can be inflated with an injectable extended use approved medical material that is delivered to the fourth expandable motion limiter 2126 via the fourth port 2144 and the fourth fluid channel 2146.
In a particular embodiment, as shown in
In a particular embodiment, the superior component 2200 includes a superior support plate 2202 that has a superior articular surface 2204 and a superior bearing surface 2206. In a particular embodiment, the superior articular surface 2204 can be generally curved and the superior bearing surface 2206 can be substantially flat. In an alternative embodiment, the superior articular surface 2204 can be flat and at least a portion of the superior bearing surface 2206 can be curved.
In a particular embodiment, after installation, the superior bearing surface 2206 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the superior bearing surface 2206 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the superior bearing surface 2206 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
The superior support plate 2202 can also include a first motion limiter engagement recess 2222, a second motion limiter engagement recess 2224, a third motion limiter engagement recess 2226, and a fourth motion limiter engagement recess 2228. In a particular embodiment, the motion limiter engagement recesses 2220, 2222, 2224, 2226 are arranged radially around the depression 2208, e.g., in a pattern that mirrors the pattern of the expandable motion limiters 2120, 2122, 2124, 2126. Further, each motion limiter engagement recess 2220, 2222, 2224, 2226 is sized and shaped to at least partially receive a corresponding expandable motion limiter 2120, 2122, 2124, 2126.
In a particular embodiment, each expandable motion limiter 2120, 2122, 2124, 2126 cooperates with a respective motion limiter engagement recess 2220, 2222, 2224, 2226 in order to limit the motion of the inferior component 2100 with respect to the superior component 2200. For example, by inflating two expandable motion limiters on one side of the depression 2108, a surgeon is able to limit flexion on that side of the depression 2108 and as such, limit the relative motion of the inferior component 2100 with respect to the superior component 2200. Further, this allows the surgeon to limit the motion of a superior vertebra with respect to an inferior vertebra.
The flexibility to alter the range of motion of the intervertebral prosthetic device 2000 provided by the expandable motion limiters 2120, 2122, 2124, 2126 can allow a surgeon to compensate for a deformity in the segment of the spinal column that includes, or is adjacent to, the superior vertebra and inferior vertebra in question. For example, if a patient's spine is curved in a particular direction, one or more motion limiters 2120, 2122, 2124, 2126 opposite the curvature can be inflated to compensate for the curvature. Before or during the surgery, the surgeon can determine any spinal deformity using an X-Ray device, a fluoroscopy device, a computed tomography (CT) device, or any other similar device well known in the art.
As illustrated in
In a particular embodiment, the overall height of the intervertebral prosthetic device 2000 can be in a range from fourteen millimeters to forty-six millimeters (14-46 mm). Further, the installed height of the intervertebral prosthetic device 2000 can be in a range from eight millimeters to sixteen millimeters (8-16 mm). In a particular embodiment, the installed height can be substantially equivalent to the distance between an inferior vertebra and a superior vertebra when the intervertebral prosthetic device 2000 is installed there between.
In a particular embodiment, the length of the intervertebral prosthetic device 2000, e.g., along a longitudinal axis, can be in a range from thirty millimeters to forty millimeters (30-40 mm). Additionally, the width of the intervertebral prosthetic device 2000, e.g., along a lateral axis, can be in a range from twenty-five millimeters to forty millimeters (25-40 mm). Moreover, in a particular embodiment, each keel 2148, 2248 can have a height in a range from three millimeters to fifteen millimeters (3-15 mm).
Although depicted in the Figures as a two piece-design, in alternative embodiments, multiple-piece designs can be employed. For example, in an alternative embodiment, the projection 2208 is not fixed or unitary with either of the support plates 2102, 2202 and, instead, is configured as a substantially rigid spherical member (not shown) that can independently articulate with each support plate 2102, 2202. Additionally or alternatively, each component can comprise multiple components (not shown). These components can articulate with or be fixed to the support plates 2102, 2202. Furthermore, expandable motion limiters can be configured to limit relative motion between any of the components described above or among multiple components.
Referring to
In a particular embodiment, the metal containing materials can be metals. Further, the metal containing materials can be ceramics. Also, the metals can be pure metals or metal alloys. The pure metals can include titanium. Moreover, the metal alloys can include stainless steel, a cobalt-chrome-molybdenum alloy, e.g., ASTM F-999 or ASTM F-75, a titanium alloy, or a combination thereof.
The polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Alternatively, the components 2700, 2800 can be made from any other substantially rigid biocompatible materials.
In a particular embodiment, the inferior component 2700 includes an inferior support plate 2702 that has an inferior articular surface 2704 and an inferior bearing surface 2706. In a particular embodiment, the inferior articular surface 2704 can be generally curved and the inferior bearing surface 2706 can be substantially flat. In an alternative embodiment, the inferior articular surface 2704 can be substantially flat and at least a portion of the inferior bearing surface 2706 can be generally curved.
In a particular embodiment, after installation, the inferior bearing surface 2706 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the inferior bearing surface 2706 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the inferior bearing surface 2706 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
As further illustrated in
For example, the polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Also, the silicone materials can include a silicone hydrogel.
In an alternative embodiment, the injectable extended use approved medical materials can include one or more fluids such as sterile water, saline, sterile air, or a combination thereof. In alternative embodiments, the expandable motion limiters can be inflated with one or more of the following: fibroblasts, lipoblasts, chondroblasts, differentiated stem cells, a combination thereof, or another biologic factor which would create a motion limiting tissue when injected into a bioresorbable motion limiting scaffold.
As shown in
As shown, the inferior support plate 2702 can also include a second port 2736 that is in fluid communication with a second fluid channel 2736 that provides fluid communication to the second expandable motion limiter 2722. The second expandable motion limiter 2722 can be inflated with an injectable extended use approved medical material that is delivered to the second expandable motion limiter 2722 via the second port 2736 and the second fluid channel 2736.
The inferior support plate 2702 can also include a fourth port 2744 that is in fluid communication with a fourth fluid channel 2746 that provides fluid communication to the fourth expandable motion limiter 2726. The fourth expandable motion limiter 2726 can be inflated with an injectable extended user approved medical material that is delivered to the fourth expandable motion limiter 2726 via the fourth port 2744 and the fourth fluid channel 2746.
In a particular embodiment, as shown in
In a particular embodiment, the superior component 2800 includes a superior support plate 2802 that has a superior articular surface 2804 and a superior bearing surface 2806. In a particular embodiment, the superior articular surface 2804 can be generally curved and the superior bearing surface 2806 can be substantially flat. In an alternative embodiment, the superior articular surface 2804 can be flat and at least a portion of the superior bearing surface 2806 can be curved.
In a particular embodiment, after installation, the superior bearing surface 2806 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the superior bearing surface 2806 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the superior bearing surface 2806 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
The superior support plate 2802 can also include a first motion limiting projection 2822, a second motion limiting projection 2824, a third motion limiting engagement 2826, and a fourth motion limiting projection 2828. In a particular embodiment, the motion limiting projections 2820, 2822, 2824, 2826 are arranged radially around the depression 2808, e.g., in a pattern that mirrors the pattern of the expandable motion limiters 2720, 2722, 2724, 2726. Further, each motion limiting projection 2820, 2822, 2824, 2826 is sized, shaped, and positioned to contact a corresponding expandable motion limiter 2720, 2722, 2724, 2726.
In a particular embodiment, each expandable motion limiter 2720, 2722, 2724, 2726 cooperates with a respective motion limiting projection 2820, 2822, 2824, 2826 in order to limit the motion of the inferior component 2700 with respect to the superior component 2800. For example, by inflating two expandable motion limiters on one side of the depression 2708, a surgeon is able to limit flexion on that side of the depression 2708 and as such, limit the relative motion of the inferior component 2700 with respect to the superior component 2800. Further, this allows the surgeon to limit the motion of a superior vertebra with respect to an inferior vertebra.
The flexibility to alter the range of motion of the intervertebral prosthetic device 2600 provided by the expandable motion limiters 2720, 2722, 2724, 2726 can allow a surgeon to compensate for a deformity in the segment of the spinal column that includes, or is adjacent to, the superior vertebra and inferior vertebra in question. For example, if a patient's spine is curved in a particular direction, one or more motion limiters 2720, 2722, 2724, 2726 opposite the curvature can be inflated to compensate for the curvature. Before or during the surgery, the surgeon can determine any spinal deformity using an X-Ray device, a fluoroscopy device, a computed tomography (CT) device, or any other similar device well known in the art.
As illustrated in
In a particular embodiment, the overall height of the intervertebral prosthetic device 2600 can be in a range from fourteen millimeters to forty-six millimeters (14-46 mm). Further, the installed height of the intervertebral prosthetic device 2600 can be in a range from eight millimeters to sixteen millimeters (8-16 mm). In a particular embodiment, the installed height can be substantially equivalent to the distance between an inferior vertebra and a superior vertebra when the intervertebral prosthetic device 2600 is installed there between.
In a particular embodiment, the length of the intervertebral prosthetic device 2600, e.g., along a longitudinal axis, can be in a range from thirty millimeters to forty millimeters (30-40 mm). Additionally, the width of the intervertebral prosthetic device 2600, e.g., along a lateral axis, can be in a range from twenty-five millimeters to forty millimeters (25-40 mm). Moreover, in a particular embodiment, each keel 2748, 2848 can have a height in a range from three millimeters to fifteen millimeters (3-15 mm).
Although depicted in the Figures as a two piece-design, in alternative embodiments, multiple-piece designs can be employed. For example, in an alternative embodiment, the projection 2808 is not fixed or unitary with either of the support plates 2702, 2802 and, instead, is configured as a substantially rigid spherical member (not shown) that can independently articulate with each support plate 2702, 2802. Additionally or alternatively, each component can comprise multiple components (not shown). These components can articulate with or be fixed to the support plates 2702, 2802. Furthermore, expandable motion limiters can be configured to limit relative motion between any of the components described above or among multiple components.
Referring to
In a particular embodiment, the metal containing materials can be metals. Further, the metal containing materials can be ceramics. Also, the metals can be pure metals or metal alloys. The pure metals can include titanium. Moreover, the metal alloys can include stainless steel, a cobalt-chrome-molybdenum alloy, e.g., ASTM F-999 or ASTM F-75, a titanium alloy, or a combination thereof.
The polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Alternatively, the components 3300, 3400 can be made from any other substantially rigid biocompatible materials.
In a particular embodiment, the superior component 3300 includes a superior support plate 3302 that has a superior articular surface 3304 and a superior bearing surface 3306. In a particular embodiment, the superior articular surface 3304 can be generally curved and the superior bearing surface 3306 can be substantially flat. In an alternative embodiment, the superior articular surface 3304 can be substantially flat and at least a portion of the superior bearing surface 3306 can be generally curved.
In a particular embodiment, after installation, the superior bearing surface 3306 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the superior bearing surface 3306 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the superior bearing surface 3306 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
As further illustrated in
For example, the polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Also, the silicone materials can include a silicone hydrogel.
In an alternative embodiment, the injectable extended use approved medical materials can include one or more fluids such as sterile water, saline, sterile air, or a combination thereof. In alternative embodiments, the expandable motion limiters can be inflated with one or more of the following: fibroblasts, lipoblasts, chondroblasts, differentiated stem cells or other biologic factor which would create a motion limiting tissue when injected into a bioresorbable motion limiting scaffold.
As shown in
As illustrated in
In a particular embodiment, the inferior component 3400 includes an inferior support plate 3402 that has an inferior articular surface 3404 and an inferior bearing surface 3406. In a particular embodiment, the inferior articular surface 3404 can be generally curved and the inferior bearing surface 3406 can be substantially flat. In an alternative embodiment, the inferior articular surface 3404 can be substantially flat and at least a portion of the inferior bearing surface 3406 can be generally curved.
In a particular embodiment, after installation, the inferior bearing surface 3406 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the inferior bearing surface 3406 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the inferior bearing surface 3406 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
In a particular embodiment, as shown in
In a particular embodiment, the overall height of the intervertebral prosthetic device 3200 can be in a range from fourteen millimeters to forty-six millimeters (14-46 mm). Further, the installed height of the intervertebral prosthetic device 3200 can be in a range from eight millimeters to sixteen millimeters (8-16 mm). In a particular embodiment, the installed height can be substantially equivalent to the distance between an inferior vertebra and a superior vertebra when the intervertebral prosthetic device 3200 is installed there between.
In a particular embodiment, the length of the intervertebral prosthetic device 3200, e.g., along a longitudinal axis, can be in a range from thirty millimeters to forty millimeters (30-40 mm). Additionally, the width of the intervertebral prosthetic device 3200, e.g., along a lateral axis, can be in a range from twenty-five millimeters to forty millimeters (25-40 mm). Moreover, in a particular embodiment, each keel 3348, 3448 can have a height in a range from three millimeters to fifteen millimeters (3-15 mm).
Although depicted in the Figures as a two piece-design, in alternative embodiments, multiple-piece designs can be employed. For example, in an alternative embodiment, the projection 3308 is not fixed or unitary with either of the support plates 3302, 3402 and, instead, is configured as a substantially rigid spherical member (not shown) that can independently articulate with each support plate 3302, 3402. Additionally or alternatively, each component can comprise multiple components (not shown). These components can articulate with or be fixed to the support plates 3302, 3402. Furthermore, expandable motion limiters can be configured to limit relative motion between any of the components described above or among multiple components.
Referring to
In a particular embodiment, the metal containing materials can be metals. Further, the metal containing materials can be ceramics. Also, the metals can be pure metals or metal alloys. The pure metals can include titanium. Moreover, the metal alloys can include stainless steel, a cobalt-chrome-molybdenum alloy, e.g., ASTM F-999 or ASTM F-75, a titanium alloy, or a combination thereof.
The polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Alternatively, the components 3900, 4000 can be made from any other substantially rigid biocompatible materials.
In a particular embodiment, the superior component 3900 includes a superior support plate 3902 that has a superior articular surface 3904 and a superior bearing surface 3906. In a particular embodiment, the superior articular surface 3904 can be generally curved and the superior bearing surface 3906 can be substantially flat. In an alternative embodiment, the superior articular surface 3904 can be substantially flat and at least a portion of the superior bearing surface 3906 can be generally curved.
In a particular embodiment, after installation, the superior bearing surface 3906 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the superior bearing surface 3906 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the superior bearing surface 3906 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
As further illustrated in
For example, the polymer materials can include polyurethane materials, polyolefin materials, polyether materials, silicone materials, or a combination thereof. Further, the polyolefin materials can include polypropylene, polyethylene, halogenated polyolefin, flouropolyolefin, or a combination thereof. The polyether materials can include polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), or a combination thereof. Also, the silicone materials can include a silicone hydrogel.
In an alternative embodiment, the injectable extended use approved medical materials can include one or more fluids such as sterile water, saline, sterile air, or a combination thereof. In alternative embodiments, the expandable motion limiters can be inflated with one or more of the following: fibroblasts, lipoblasts, chondroblasts, differentiated stem cells or other biologic factor which would create a motion limiting tissue when injected into a bioresorbable motion limiting scaffold.
As shown in
As illustrated in
In a particular embodiment, the inferior component 4000 includes an inferior support plate 4002 that has an inferior articular surface 4004 and an inferior bearing surface 4006. In a particular embodiment, the inferior articular surface 4004 can be generally curved and the inferior bearing surface 4006 can be substantially flat. In an alternative embodiment, the inferior articular surface 4004 can be substantially flat and at least a portion of the inferior bearing surface 4006 can be generally curved.
In a particular embodiment, after installation, the inferior bearing surface 4006 can be in direct contact with vertebral bone, e.g., cortical bone and cancellous bone. Further, the inferior bearing surface 4006 can be coated with a bone-growth promoting substance, e.g., a hydroxyapatite coating formed of calcium phosphate. Additionally, the inferior bearing surface 4006 can be roughened prior to being coated with the bone-growth promoting substance to further enhance bone on-growth. In a particular embodiment, the roughening process can include acid etching; knurling; application of a bead coating, e.g., cobalt chrome beads; application of a roughening spray, e.g., titanium plasma spray (TPS); laser blasting; or any other similar process or method.
As illustrated in
In a particular embodiment, as shown in
In a particular embodiment, the overall height of the intervertebral prosthetic device 3800 can be in a range from fourteen millimeters to forty-six millimeters (14-46 mm). Further, the installed height of the intervertebral prosthetic device 3800 can be in a range from eight millimeters to sixteen millimeters (8-16 mm). In a particular embodiment, the installed height can be substantially equivalent to the distance between an inferior vertebra and a superior vertebra when the intervertebral prosthetic device 3800 is installed there between.
In a particular embodiment, the length of the intervertebral prosthetic device 3800, e.g., along a longitudinal axis, can be in a range from thirty millimeters to forty millimeters (30-40 mm). Additionally, the width of the intervertebral prosthetic device 3800, e.g., along a lateral axis, can be in a range from twenty-five millimeters to forty millimeters (25-40 mm). Moreover, in a particular embodiment, each keel 3948, 4048 can have a height in a range from three millimeters to fifteen millimeters (3-15 mm).
Although depicted in the Figures as a two piece-design, in alternative embodiments, multiple-piece designs can be employed. For example, in an alternative embodiment, the projection 3908 is not fixed or unitary with either of the support plates 3902, 4002 and, instead, is configured as a substantially rigid spherical member (not shown) that can independently articulate with each support plate 3902, 4002. Additionally or alternatively, each component can comprise multiple components (not shown). These components can articulate with or be fixed to the support plates 3902, 4002. Furthermore, expandable motion limiters can be configured to limit relative motion between any of the components described above or among multiple components.
Referring to
As shown in
As illustrated in
In a particular embodiment, as depicted in
As shown in
In particular, the stop cock 4460 can include a first fluid transfer channel 4462, a second fluid transfer channel 4464, a third fluid transfer channel 4466, and a fourth fluid transfer channel 4468 established radially therethrough. In a particular embodiment, the fluid transfer channels 4462, 4464, 4466, 4468 can be established within the stop cock 4460 so that the secondary fluid channels 4446, 4448, 4450, 4452 can communicate with the primary fluid channel 4444 via the stop cock 4460 individually, i.e., one at a time. For example, the fluid transfer channels 4462, 4464, 4466, 4468 can be established at different locations linearly along the stop cock 4460 and at different radial angles through the stop cock 4460.
In a particular embodiment, the stop cock 4460 can be rotated by turning a knob 4470 that is coupled thereto. As the stop cock 4460 is rotated to one of four fluid transfer positions, a fluid transfer channel 4462, 4464, 4466, 4468 can communicate fluid from the primary fluid channel 4444 to a corresponding secondary fluid channel 4446, 4448, 4450, 4452 and injector 4430, 4432, 4434, 4436. As such, abuser, e.g., a surgeon, can select which injector 4430, 4432, 4434, 4436 can be used to inject a fluid into an expandable motion limiter, e.g., an expandable motion limiter according to one of the embodiments disclosed herein.
Referring to
As shown in
As illustrated in
In a particular embodiment, as depicted in
As illustrated in
As shown in
In particular, the stop cock 4970 can include a first fluid transfer channel 4972, a second fluid transfer channel 4974, a third fluid transfer channel 4976, and a fourth fluid transfer channel 4978 established radially therethrough. In a particular embodiment, the fluid transfer channels 4972, 4974, 4976, 4978 can be established within the stop cock 4970 so that the secondary fluid channels 4956, 4958, 4960, 4962 can communicate with the primary fluid channel 4954 via the stop cock 4970 individually, i.e., one at a time. For example, the fluid transfer channels 4972, 4974, 4976, 4978 can be established at different locations linearly along the stop cock 4970 and at different radial angles through the stop cock 4970.
In a particular embodiment, the stop cock 4970 can be rotated by turning a knob 4980 that is coupled thereto. As the stop cock 4970 is rotated to one of four fluid transfer positions, a fluid transfer channel 4972, 4974, 4976, 4978 can communicate fluid from the primary fluid channel 4954 to a corresponding secondary fluid channel 4956, 4958, 4960, 4962 and injector 4930, 4932, 4934, 4936. As such, a user, e.g., a surgeon, can select which injector 4930, 4932, 4934, 4936 can be used to inject a fluid into an expandable motion limiter, e.g., an expandable motion limiter according to one of the embodiments disclosed herein.
Referring to
As shown in
As illustrated in
In a particular embodiment, as depicted in
In a particular embodiment, the body 5302 can be formed with a first inferior fluid channel 5364 that is in fluid communication with the first inferior plunger chamber 5344. Further, the first inferior fluid channel 5364 can communicate with the first inferior injector 5334. The body 5302 can also be formed with a fourth inferior fluid channel 5366 that is in fluid communication with the second inferior plunger chamber 5346. The second inferior fluid channel 5366 can communicate with the second inferior injector 5336.
During use, a user, e.g., a surgeon, can select which injector 5330, 5332, 5334, 5336 can be used to inject a fluid into an expandable motion limiter, e.g., an expandable motion limiter according to one of the embodiments disclosed herein, by selecting a corresponding plunger 5350, 5352, 5354, 5356. The selected plunger 5350, 5353, 5354, 5356 can be slid into the corresponding plunger chamber 5350, 5342, 5344, 5346 in order to force material from within the plunger chamber 5350, 5342, 5344, 5346 to travel through the fluid channel 5360, 5362, 5364, 5366 and exit through the selected injector 5330, 5332, 5334, 5336.
Referring to
As shown in
As illustrated in
With the configuration of structure described above, the intervertebral prosthetic disc according to one or more of the embodiments provides a device that may be implanted to replace a natural intervertebral disc that is diseased, degenerated, or otherwise damaged. The intervertebral prosthetic disc can be disposed within an intervertebral space between an inferior vertebra and a superior vertebra. Further, after a patient fully recovers from a surgery to implant the intervertebral prosthetic disc, the intervertebral prosthetic disc can provide relative motion between the inferior vertebra and the superior vertebra that closely replicates the motion provided by a natural intervertebral disc. Accordingly, the intervertebral prosthetic disc provides an alternative to a fusion device that can be implanted within the intervertebral space between the inferior vertebra and the superior vertebra to fuse the inferior vertebra and the superior vertebra and prevent relative motion there between.
During implantation, the surgeon can engage an intervertebral prosthetic disc with an implant inserter, e.g., an implant inserter according to one or more of the embodiments described herein, and use the implant inserter to implant the intervertebral prosthetic disc and inflate at least one expandable motion limiter incorporated into the intervertebral prosthetic disc. After the expandable motion limiter is inflated, the implant inserter can be disengaged from the intervertebral prosthetic implant and removed.
A surgeon may inflate the expandable motion limiter in order to limit the motion of a superior component with respect to an inferior component. As such, the surgeon can limit the motion of a superior vertebra with respect to an inferior vertebra. The flexibility to alter the range of motion of an intervertebral prosthetic device that is configured according to one or more of the embodiments disclosed herein can allow a surgeon to compensate for a deformity in the segment of the spinal column that includes, or is adjacent to, the superior vertebra and inferior vertebra in question. As such, a patient may be given a chance to recover from disc implant surgery with greater mobility than the mobility provided by a fusion device.
It can be appreciated that more than one of the features described above can be combined in another embodiment of an intervertebral prosthetic device. For example, one or more expandable motion limiters can extend from a superior component and one or more expandable motion limiters can extend from an inferior component. Each of the expandable motion limiters can be injected with material in order to limit the motion of the superior component with respect to the inferior component.
The above-disclosed subject matter is to be considered illustrative, and not restrictive, and the appended claims are intended to cover all such modifications, enhancements, and other embodiments that fall within the true spirit and scope of the present invention. For example, it is noted that the components in the exemplary embodiments described herein are referred to as “superior” and “inferior” for illustrative purposes only and that one or more of the features described as part of or attached to a respective half may be provided as part of or attached to the other half in addition or in the alternative. Thus, to the maximum extent allowed by law, the scope of the present invention is to be determined by the broadest permissible interpretation of the following claims and their equivalents, and shall not be restricted or limited by the foregoing detailed description.